Evidence map›Paper›PMID 25003343›Full record

ArticlePloS one2014

Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9.

Rui Huang, Lu Zhang, Qin Gu, Yi-Hua Zhou, Yingying Hao, Kui Zhang, Yong Liu, Danjiang Dong, Shixia Wang, Zuhu Huang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2017
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Rui HuangDepartment of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Lu ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qin GuDepartment of Intensive Care Units, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Yi-Hua ZhouDepartment of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Jiangsu Key Laboratory for Molecular Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Yingying HaoDepartment of Intensive Care Units, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Kui ZhangDepartment of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Yong LiuDepartment of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Jiangsu Key Laboratory for Molecular Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Danjiang DongDepartment of Intensive Care Units, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Shixia WangChina-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Zuhu HuangDepartment of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Shan LuChina-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Chao WuDepartment of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Nanjing Drum Tower Hospital · CNJiangsu Province Hospital · CNNanjing Medical University · CNNanjing University of Chinese Medicine · CNUniversity of Massachusetts Chan Medical School · US

Funding

Multi-gene Subunit Vaccine Platform Against Y. pestisU01AI078073 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LU, SHAN · 2008 to 2011
$1.7M
NIAID NIH HHS 5U01AI078073-04NIAID NIH HHS U01 AI078073
6 · The paper itself

Abstract

The influenza A H7N9 virus outbreak in Eastern China in the spring of 2013 represented a novel, emerging avian influenza transmission to humans. While clinical and microbiological features of H7N9 infection have been reported in the literature, the current study investigated acute cytokine and antibody responses in acute H7N9 infection. Between March 27, 2013 and April 23, 2013, six patients with confirmed H7N9 influenza infection were admitted to Drum Tower Hospital, Nanjing, China. Acute phase serum cytokine profiles were determined using a high-throughput multiplex assay. Daily H7 hemagglutinin (HA)-specific IgG, IgM, and IgA responses were monitored by ELISA. Neutralizing antibodies specific for H7N9 viruses were determined against a pseudotyped virus expressing the novel H7 subtype HA antigen. Five cytokines (IL-6, IP-10, IL-10, IFNγ, and TNFα) were significantly elevated in H7N9-infected patients when compared to healthy volunteers. Serum H7 HA-specific IgG, as well as IgM and IgA responses, were detected within 8 days of disease onset and increased in a similar pattern during acute infection. Neutralizing antibodies developed shortly after the appearance of binding antibody responses and showed similar kinetics as a fraction of the total H7 HA-specific IgG responses. H7N9 infection resulted in hallmark serum cytokine increases, which correlated with fever and disease persistence. The novel finding of simultaneous development of IgG, IgM, and IgA responses in acute H7N9 infection points to the potential for live influenza viruses to elicit fast and potent protective antibodies to limit the infection.

Indexed as

AdultAntibodies, NeutralizingAntibodies, ViralAntibody SpecificityCase-Control StudiesChemokinesCytokinesFemaleFeverHumansImmunoglobulin GImmunoglobulin IsotypesInfluenza A Virus, H7N9 SubtypeInfluenza, HumanMaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralChemokinesCytokinesImmunoglobulin GImmunoglobulin Isotypes

Identifiers

PMID25003343
PMCPMC4086936
OpenAlexW1985074341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.